⏺️ Recorded October 2, 2025
PMCF surveys can strengthen your CER and PSUR or create rework. In this 60-minute panel with live audience Q&A, RQM+ leaders from regulatory, clinical, and scientific writing share what MDR reviewers look for and how to design surveys that generate decision-grade evidence. The session is intended for regulatory affairs, post-market surveillance, clinical evidence, and medical writing leaders at MedTech manufacturers.
Join to learn how to:
- Define clear objectives, endpoints, and target population so the survey maps to your PMCF plan and CER.
- Improve response rates without bias and capture higher-quality data, including adverse events and usability feedback.
- Learn how to position your physician level survey as a chart review.
- Document methods, rationales, and traceability so notified bodies can follow the logic.
- Avoid the top reasons reviewers push back on PMCF surveys and how to correct them.
Walk away with a practical checklist to pressure test your next PMCF survey and reduce review risk.
Who should attend:
- Regulatory affairs leaders and PMS managers.
- Clinical evidence and clinical operations leads.
- Scientific and medical writing leaders, including CER and PSUR authors.
- Quality leaders responsible for post market surveillance programs.
Panelists and moderator:
- Torrie DeGennaro – Vice President, Scientific & Medical Writing
- Bethany Chung, Ph.D., RAC – Director, Technical Solutions & Innovation
- Garrett Jeffries, Ph.D. – Principal
- Jon Gimbel, Ph.D. – Vice President, Regulatory Affairs
Certificate of attendance available upon request for live attendees.
Watch Now ▶️
Fields marked with * are required.
